Determination of kinetic parameters of decomposition of tetrahydropyrimidine derivatives
Available online at www.ilcpa.pl
International Letters of Chemistry, Physics and Astronomy
13 (2013) 23-32
ISSN 2299-3843
Determination of kinetic parameters of
decomposition of tetrahydropyrimidine derivatives
Kapil Bhesaniya, Ashish Patel, Shipra Baluja*
Department of Chemistry, Saurashtra University, Rajkot-360 005, Gujarat, India
*E-mail address:
ABSTRACT
Some new tetrahydropyrimidine derivatives have been synthesized and their structural
determination was done by IR, NMR and mass spectral data. Thermal analysis of these synthesized
dihydropyrimidinthiones has been carried out by TGA and DSC techniques. From the thermograms,
various kinetic parameters such as order of degradation (n), energy of activation (E), frequency factor
(A) and entropy change (∆S) have been evaluated. Further, thermal stability of tetrahydropyrimidine
have been determined which is found to depend on the type of substituent present in the compounds.
Keywords: Tetrahydropyrimidine derivative; TGA, DSC; kinetic parameter
1. INTRODUTION
Synthesis of tetrahydropyrimidine and their derivatives is of high interest in organic
chemistry. The pyrimidine fragment is present in various biologically active compounds,
many of which have been found use in medical practice1,2. Thus, recently, much attention has
been paid to derivatives of pyrimidine, including their hydrogenation products. This class of
compounds displays wide ranges of biological and pharmacological properties such as antiinflammatory3-5, analgesic6,7, antitumor8,9, antidepressant10, antibacterial and antifungal
effects 11-13. For the complete development of a new drug, thermal analysis has many
applications14,15. The information obtained regarding the compounds under study is useful for
the initial chemical research phase16. In the chemical research phase, thermal analysis plays an
important role. The purity of the compound, the compounds ability to be able to exist in
various crystalline forms as well as to characterize polymorphs and other forms of solid state
should be investigated. It also makes possible to determine optimum conditions of storage of
drugs and to define the parameters of technological processes, which can be used without loss
of specific physicochemical properties of a drugs17,18. The application of these compounds in
pharmaceutical field prompted us to study their thermal stability. In present study, some new
tetrahydropyrimidines have been synthesized and characterization of these synthesized
compounds is done by IR, NMR and mass spectral data. The thermal analysis of some new
synthesized tetrahydropyrimidine derivatives has been done by DSC and TGA techniques.
International Letters of Chemistry, Physics and Astronomy 13 (2013) 23-32
2. EXPERIMENTAL SECTION
Synthesis of 2,4-diamino-6-phenyl-1,4,5,6-tetrahydropyrimidine-5-carbonitrile
(PAB-101 - PAB-110): A solution of substituted aldehyde (0.01 mole), malenonitrile (0.01
mole), freshly prepared sodium ethoxide (30 ml) and guanidine hydrochloride (0.01 mole)
was refluxed for 12 hours. The reaction mixture was poured into crushed ice and the solution
was neutralized with aqueous HCl solution. The product was extracted using chloroform.
The formation of the compounds was checked by thin-layer chromatography and
accomplished on 0.2-mm pre coated plates of silica gel G60 F254 (Merck). Visualization was
made with UV light (254 and 365nm) or with an iodine vapor.
The melting point of all the synthesized compounds was determined in open capillary
tubes and was uncorrected.
The characterization of all these compounds was done by IR, NMR and mass spectral
data. The IR spectra were recorded on Shimadzu FT-IR-8400 instrument using KBr pellet
method. The Mass spectra were recorded on Shimadzu GC-MS-QP-2010 model using direct
inlet probe technique. 1H NMR and 13C NMR was determined in DMSO solution on a Bruker
Ac 400 MHz spectrometer.
The physical constants of all the synthesized compounds are given in Table 1.
Table 1. Physical properties of substituted tetrahydropyrimidine.
Code
R
M.F
Yield (%)
Rf value
m. p. (°C)
PAB-101
C 6 H5 -
C11H13N5
78
0.68
141-143
PAB-102
C6H4-CH=CH-
C13H15N5
60
0.73
112-114
PAB-103
3-Cl,C6H4-
C11H12ClN5
68
0.44
153-155
PAB-104
4-Cl,C6H4-
C11H12ClN5
66
0.46
162-164
PAB-105
4-F,C6H4-
C12H15FN5
62
0.52
128-130
PAB-106
4-OCH3,C6H4-
C12H15N5O
84
0.42
116-118
PAB-107
C11H12N6O2
60
0.62
141-143
C12H15N5O2
74
0.34
132-134
PAB-109
3-NO2,C6H43-OCH3,
4-OHC6H44(α-C4H3O)-
C9H11N5O
82
0.36
72-74
PAB-110
4-OH-C6H4-
C11H13N5O
56
0.30
176-178
PAB-108
24
International Letters of Chemistry, Physics and Astronomy 13 (2013) 23-32
3. SPECTRAL DATA
2,4-diamino-6-phnyl-1,4,5,6-tetrahydropyrimidine-5-carbonitrile (PAB-101).
IR (KBr): 3151(N-H str), 3093(Ar, C-H str), 2943(C-Hstr), 2867(C-H str), 2245(C≡N str),
1610(Ar, C=C str), 1519(Ar, C=C str), 1512(Ar, C=C str), 1490(C-H ben), 1427(C-H ben),
1377(C-H ben), 1265(C-Cstr) cm-1; 1H NMR (400 MHz, DMSO): δ ppm 2.59 (s, 1H, -CH)
3.22-3.36 (t, 1H, -CH), 4.09-4.12 ( d, J = 9.81 Hz 1H, -CH), 6.29 (s, 2H, NH2), 6.66(s, 2H,
NH2), 8.38-8.42 (m, 5H, Ar-H), 8.64 (s, 1H, -NH). MS: m/z = 215 [M ]+
2,4-diamino-6-styryl-1,4,5,6-tetrahydropyrimidine-5-carbonitrile (PAB-102).
IR (KBr): 3161(N-H str), 3021(CH=CH str), 3091(Ar, C-H str), 2952(C-Hstr), 2879(C-H str),
2267(C≡N str), 1609(Ar, C=C str), 1515(Ar, C=C str), 1508(Ar, C=C str), 1481(C-H ben),
1425(C-H ben), 1379(C-H ben), 1252(C-C str) cm-1; 1H NMR (400 MHz, DMSO): δ ppm 2.55
(s, 1H, -CH) 3.29-3.37 (t, 1H, -CH), 4.05-4.18 ( dd, J = 9.79 Hz 1H, -CH), 5.04-5.07(dd, 1H –
CH, J=8.24), 6.32 (s, 2H, NH2), 6.6(s, 2H, NH2), 8.34-8.39 (m, 5H, Ar-H), 8.74 (s, 1H, -NH).
MS: m/z = 241 [M ]+
2,4-diamino-6-(3-chlorophenyl)-1,4,5,6-tetrahydropyrimidine-5-carbonitrile(PAB-103)
IR (KBr): 3163(N-H str), 3097(Ar, C-H str), 2933(C-Hstr), 2877(C-H str), 2265(C≡N str),
1608(Ar, C=C str), 1514(Ar, C=C str), 1502(Ar, C=C str), 1489(C-H ben), 1421(C-H ben),
1371(C-H ben), 1255(C-Cstr), 744(C-Cl str) cm-1; 1H NMR (400 MHz, DMSO): δ ppm 2.61
(s, 1H, -CH) 3.30-3.34 (t, 1H, -CH), 4.07-4.09 ( d, J = 9.78 Hz 1H, -CH), 6.21 (s, 2H, NH2),
6.68(s, 2H, NH2), 7.82-7.87 (t, 1H, Ar-H), 8.39-8.42 (d, 1H, Ar-H), 8.44-8.49 (m, 1H, Ar-H),
8.64 (s, 1H, -NH), 8.81(s, 1H, Ar-H). MS: m/z = 249 [M ]+.
2,4-diamino-6-(4-chlorophenyl)-1,4,5,6-tetrahydropyrimidine-5-carbonitrile(PAB-104).
IR (KBr): 3167(N-H str), 3092(Ar, C-H str), 2942(C-Hstr), 2876(C-H str), 2260(C≡N str),
1609(Ar, C=C str), 1508(Ar, C=C str), 1518(Ar, C=C str), 1481(C-H ben), 1422(C-H ben),
1376(C-H ben), 1250(C-Cstr), 742(C-Cl str) cm-1; 1H NMR (400 MHz, DMSO): δ ppm 2.63
(s, 1H, -CH) 3.24-3.29 (t, 1H, -CH), 4.12-4.15 ( d, J = 9.78 Hz 1H, -CH), 6.21 (s, 2H, NH2),
6.63(s, 2H, NH2), 7.82-7.87 (dd, 2H, Ar-H), 8.39-8.42 (dd, 2H, Ar-H), 8.64 (s, 1H, -NH). MS:
m/z = 249 [M ]+.
2,4-diamino-6-(4-fluorophenyl)-1,4,5,6-tetrahydropyrimidine-5-carbonitrile (PAB-105).
IR (KBr): 3170(N-H str), 3094(Ar, (...truncated)